Edge Therapeutics, Inc. (EDGE) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 110 transactions totaling $16.5M, demonstrating a bullish sentiment with $13.7M in net insider flow. The most recent transaction on Mar 15, 2019 involved a transaction of 20,000 shares valued at $0.
No significant insider buying has been recorded for EDGE in the recent period.
No significant insider selling has been recorded for EDGE in the recent period.
Based on recent SEC filings, insider sentiment for EDGE is bullish with an Insider Alignment Score of 91/100 and a net flow of $13.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Edge Therapeutics, Inc. (EDGE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading EDGE stock, having executed 110 transactions in the past 90 days. The most active insider is James Healy (Executive), who has made 4 transactions totaling $9.4M.
Get notified when executives and directors at EDGE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 15, 2019 | J. Barer Sol | Executive | Option Exercise | 20,000 | $N/A | $0 | |
| Mar 15, 2019 | A. Crane Rosemary | Executive | Option Exercise | 10,000 | $N/A | $0 | |
| Mar 15, 2019 | Blech Isaac | Executive | Option Exercise | 10,000 | $N/A | $0 | |
| Mar 15, 2019 | Blech Isaac | Executive | Option Exercise | 10,000 | $N/A | $0 | |
| Mar 15, 2019 | A. Leuthner Brian | Executive | Option Exercise | 169,032 | $N/A | $0 | |
| Mar 15, 2019 | J. Loughlin James | Executive | Option Exercise | 10,000 | $N/A | $0 | |
| Mar 15, 2019 | Bradford Middlekauff W. | Executive | Option Exercise | 49,766 | $N/A | $0 | |
| Mar 15, 2019 | Ratcliffe Liam | Executive | Option Exercise | 10,000 | $N/A | $0 | |
| Mar 15, 2019 | Saik Andrew | Executive | Option Exercise | 82,999 | $N/A | $0 | |
| Mar 15, 2019 | J. Spiegel Robert | Executive | Option Exercise | 10,000 | $N/A | $0 | |
| Mar 15, 2019 | Loch Macdonald R. | Executive | Option Exercise | 10,000 | $N/A | $0 | |
| Mar 23, 2018 | G. Conti Kurt | Executive | Other | 58,476 | $N/A | $0 | |
| Mar 22, 2018 | Loch Macdonald R. | Executive | Sale | 2,500 | $16.41 | $41.0K | |
| Mar 21, 2018 | Loch Macdonald R. | Executive | Sale | 2,500 | $16.52 | $41.3K | |
| Mar 20, 2018 | Loch Macdonald R. | Executive | Sale | 5,000 | $16.47 | $82.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 20 | $15.1M | 85.7% |
Sale(S) | 40 | $1.4M | 8.1% |
Other(J) | 11 | $990.5K | 5.6% |
Exercise(M) | 13 | $76.7K | 0.4% |
Exercise (Options)(X) | 2 | $33.7K | 0.2% |
Conversion(C) | 24 | $0 | 0.0% |
Insiders at Edge Therapeutics, Inc. are accumulating shares at an accelerated pace. With 17 insiders making 110 transactions totaling $15.1M in purchases versus $1.4M in sales, the net buying activity of $13.7M signals strong executive confidence. James Healy (Executive) leads the buying activity with $9.4M in transactions across all time.